June 17, 2026 Prometheus Hyperscale Secures Unanimous Conditional Use Permit Approval from Uinta County Commissioners
June 17, 2026 Cenna Biosciences Receives FDA Clearance to Begin Phase 1a/1b Clinical Trial of 8M2D, a First-in-Class Peptide Designed to Stop the Production of Amyloid in Alzheimer’s Disease
